Jhoti Sumitra
Universitas Mohammad Natsir

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Analysis of The Implementation of Pharmaceutical Service Standards at Granmed Lubuk Pakam Hospital Jhoti Sumitra; Miftahul Jannah; Yosi Darmirani
Jurnal FARMASIMED (JFM) Vol 8 No 2 (2026): Jurnal Farmasimed (JFM)
Publisher : Fakultas Farmasi Institut Kesehatan Medistra Lubuk Pakam

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35451/v82hvz23

Abstract

Background: Pharmaceutical care involve direct interaction and responsibility of pharmacists to patients regarding pharmaceutical products with the aim of achieving clear outcomes to improve patients' quality of life. To enhance the quality of pharmaceutical care in hospitals, the Minister of Health Regulation No. 72 of 2016 on Standards of Pharmaceutical Services in Hospitals was established. Pharmacists have the duty to provide advice, information, and education related to the medications received by patients, as well as assist patients in implementing a healthy lifestyle to ensure the success of the treatment. They also monitor the outcomes of the therapies that patients have undergone and collaborate with other healthcare professionals with the goal of improving patients' quality of life. Objective: To analyze the implementation of the Minister of Health Regulation No. 72 of 2016 on Standards of Pharmaceutical care Hospital in relation to patient satisfaction. Method: cross-sectional in nature. The collected data were compared with standards listed in the literature and analyzed using the Chi-Square method. Results: it was found that 25 individuals (42.4%) who responded felt that clinical pharmacy services were unsatisfactory, while 34 individuals (57.6%) felt that the clinical pharmacy services were quite good. Conclusion: the implementation of PMK No. 72 of 2016. There is a relationship between clinical pharmacy care and patient satisfaction at Granmed Lubuk Pakam Hospital (p value = 0.007).
Evaluation of Anemia Medication Use in One-Day Care Patients with Chronic Kidney Disease at the Hemodialysis Unit of RSUD Dr. Achmad Mochtar Bukittinggi Miftahul Jannah; Rido Farnandi; Jhoti Sumitra; Linda Hevira; Puteri Angeli
Jurnal FARMASIMED (JFM) Vol 9 No 1 (2026): Jurnal Farmasimed (JFM)
Publisher : Fakultas Farmasi Institut Kesehatan Medistra Lubuk Pakam

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35451/jfm.v9i1.3662

Abstract

Background: Chronic Kidney Disease (CKD) is a progressive impairment of renal function that frequently triggers renal anemia complications due to decreased erythropoietin hormone production. At RSUD Dr. Achmad Mochtar Bukittinggi, the service load of the Hemodialysis Unit is exceptionally high, making the evaluation of anemia therapy rationality crucial to ensure treatment efficacy. Objective: To evaluate patient characteristics, drug use patterns, and the level of drug use rationality for anemia therapy in One Day Care CKD patients undergoing hemodialysis. Methods: This descriptive observational study with a prospective approach involved 120 end-stage CKD respondents in January 2026. Data were collected through structured interviews and medical data verification. Results: The findings showed that respondents were predominantly male (59.17%), with the highest age group being 56–65 years old (30.83%). The therapeutic pattern indicated 100% erythropoietin use, 90.00% folic acid, 5.83% blood booster tablets, and 1.67% Sangobion. Rationality evaluation based on the 4T indicators (Right Patient, Right Drug, Right Indication, Right Dosage) demonstrated that correct patient, drug, and indication reached 100%. However, dosage accuracy was only 10.00%, where 90.00% of patients received a folic acid dose of 1–3 mg/day, which falls below the hospital's Clinical Practice Guidelines (CPG) standard of 5 mg/day. Conclusion: Overall, anemia therapy was appropriate regarding the right patient, right drug, and right indication, but requires significant correction in the folic acid dosage regimen.